Log in

Relevant bibliographies by topics / Mifepristone Contraceptives

Contents

Journal articles
Dissertations / Theses
Books
Book chapters

Academic literature on the topic 'Mifepristone Contraceptives'

Author: Grafiati

Published: 4 June 2021

Last updated: 6 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mifepristone Contraceptives.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Mifepristone Contraceptives"

1

Schmidt-Hansen, Mia, James E. Hawkins, Jonathan Lord, et al. "Long-acting reversible contraception immediately after medical abortion: systematic review with meta-analyses." Human Reproduction Update 26, no. 2 (2020): 141–60. http://dx.doi.org/10.1093/humupd/dmz040.

Full text

Abstract:

Abstract BACKGROUND Long-acting reversible contraceptives (LARCs) are safe, effective and convenient post-abortal methods. However, there is concern that some LARCs may reduce the effectiveness of abortifacient drugs or result in other adverse outcomes. OBJECTIVE AND RATIONALE We undertook two systematic reviews to examine the early administration of LARCs in women undergoing medical abortion with mifepristone and misoprostol. (i) For women who are having a medical abortion and who plan to use a progestogen-only contraceptive implant or injectable, does administration of the contraception at t

APA, Harvard, Vancouver, ISO, and other styles

2

Morison, Naomi B., Tu'uhevaha J. Kaitu'u-Lino, Ian S. Fraser, and Lois A. Salamonsen. "Stimulation of epithelial repair is a likely mechanism for the action of mifepristone in reducing duration of bleeding in users of progestogen-only contraceptives." REPRODUCTION 136, no. 2 (2008): 267–74. http://dx.doi.org/10.1530/rep-08-0076.

Full text

Abstract:

Many women using progestogen (P)-only contraceptives experience uterine bleeding problems. In clinical trials, a single low dose of mifepristone, given to Implanon users at the beginning of a bleeding episode reduced the number of bleeding days by ∼50% compared with controls. In this study, a single dose of mifepristone was administered to etonogestrel (ENG)-exposed pseudo-pregnant mice, 5 days after artificial decidualization was induced when the endometrium showed signs of bleeding. Control mice received vehicle alone. Mice were culled 12-, 18-, 24- and 48-h post-treatment. In the continued

APA, Harvard, Vancouver, ISO, and other styles

3

Sergheyev, P. V., Ye N. Kareva, N. Yu Tkacheva, and M. M. Vysotsky. "Antiprogestines." Problems of Endocrinology 40, no. 3 (1994): 52–54. http://dx.doi.org/10.14341/probl12051.

Full text

Abstract:

Antiprogestins are steroid compounds that have a high ability to bind to progesterone cell receptors and thus prevent their binding to endogenous steroid hormone. The first achievements in the search for progesterone antagonists were obtained in the laboratories of well-known companies Roussel-Uclaf and Schering AG, where hundreds of Hp-arylsteroid derivatives were synthesized, of which the most common were mifepristone (RU 38486), lilopristone (ZK 08734), onapriston (ZK 08200 ) At present, antiprogestins are used as implantation inhibitors, contraceptives, drugs used in Itsenko-Cu

APA, Harvard, Vancouver, ISO, and other styles

4

Hannaford, P. "Single dose mifepristone, single dose levonorgestrel, or 2 dose levonorgestrel were effective emergency contraceptives." Evidence-Based Medicine 8, no. 4 (2003): 119. http://dx.doi.org/10.1136/ebm.8.4.119.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Ho, Pak Chung, Ernest Hung Yu Ng, and Oi Shan Tang. "Mifepristone: contraceptive and non-contraceptive uses." Current Opinion in Obstetrics and Gynecology 14, no. 3 (2002): 325–30. http://dx.doi.org/10.1097/00001703-200206000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Mifepristone: potential contraceptive agent?" Inpharma Weekly &NA;, no. 1054 (1996): 11. http://dx.doi.org/10.2165/00128413-199610540-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

HEIKINHEIMO, OSKARI, and DAVID F. ARCHER. "Mifepristone: A Potential Contraceptive." Clinical Obstetrics and Gynecology 39, no. 2 (1996): 461–68. http://dx.doi.org/10.1097/00003081-199606000-00019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Ho, Pak Chung. "Mifepristone: a potential postcoital contraceptive." Expert Opinion on Pharmacotherapy 2, no. 9 (2001): 1383–88. http://dx.doi.org/10.1517/14656566.2.9.1383.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Koyama, Atsuko, Laura Hagopian, and Judith Linden. "Emerging Options for Emergency Contraception." Clinical Medicine Insights: Reproductive Health 7 (January 2013): CMRH.S8145. http://dx.doi.org/10.4137/cmrh.s8145.

Full text

Abstract:

Emergency post-coital contraception (EC) is an effective method of preventing pregnancy when used appropriately. EC has been available since the 1970s, and its availability and use have become widespread. Options for EC are broad and include the copper intrauterine device (IUD) and emergency contraceptive pills such as levonorgestrel, ulipristal acetate, combined oral contraceptive pills (Yuzpe method), and less commonly, mifepristone. Some options are available over-the-counter, while others require provider prescription or placement. There are no absolute contraindications to the use of emer

APA, Harvard, Vancouver, ISO, and other styles

10

Marions, Lena, Kristina Gemzell Danielsson, Marja-Liisa Swahn, and Marc Bygdeman. "Contraceptive efficacy of low doses of mifepristone." Fertility and Sterility 70, no. 5 (1998): 813–16. http://dx.doi.org/10.1016/s0015-0282(98)00306-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Mifepristone Contraceptives"

1

Sun, Xiaoxi. "Effects of mifepristone on the human endometrium and the fallopian tube during the luteal phase /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-346-9/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Narvekar, N. N. "Towards developing a new contraceptive pill : effects of mifepristone on reproductive tissues and menstrual cycle." Thesis, University of Edinburgh, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.659879.

Full text

Abstract:

The first study investigates the effect of daily low-dose mifepristone on proliferation markers [phospho-histone H3 (pH3) mitosis marker] and steroid receptors [oestrogen receptor, progesterone receptor, androgen receptor (AR)] in the endometrium. There was a significant down-regulation in pH3 and PR expression following mifepristone treatment whereas AR expression was up-regulated. Since androgens antagonize oestrogen-effects on the endometrium, mifepristone-induced AR up-regulation could play a role in its anti-proliferative effects. The second study investigates the effects of daily low-dos

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Mifepristone Contraceptives"

1

Chalker, Rebecca. A woman's book of choices: Abortion, menstrual extraction, RU-486. Four Walls Eight Windows, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Baulieu, Etienne-Emile. The "abortion pill": RU-486, a woman's choice. Simon & Schuster, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Mort, Rosenblum, ed. The abortion pill. Century, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Contraception and abortion from the ancient world to the Renaissance. Harvard University Press, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Riddle, John M. Contraception and Abortion from the Ancient World to the Renaissance. Harvard U.P., 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Contraception and abortion from the ancient world to the Renaissance. Harvard University Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy. RU 486: The import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. U.S. G.P.O., 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

United, States Congress House Committee on Small Business Subcommittee on Regulation Business Opportunities and Energy. RU 486: The import ban and its effect on medical research : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred First Congress, second session, Washington, DC, November 19, 1990. U.S. G.P.O., 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Klein, Renate, Lynette J. Dumble, and Janice G. Raymond. Ru 486 Misconceptions Myths and Morals. Spinifex Pr, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Herbert, Barbara, Barbara Ehrenreich, Carol Downer, and Rebecca Chalker. Woman's Book of Choices: Abortion, Menstrual Extraction, RU-486. Seven Stories Press, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Mifepristone Contraceptives"

1

Li, Hang Wun Raymond, and Pak Chung Ho. "Termination of pregnancy." In Oxford Textbook of Obstetrics and Gynaecology, edited by Sabaratnam Arulkumaran, William Ledger, Lynette Denny, and Stergios Doumouchtsis. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198766360.003.0054.

Full text

Abstract:

When an unintended pregnancy occurs secondary to contraceptive failure, the availability of safe means of pregnancy termination is important to minimize morbidities and mortalities associated with the abortion procedure. Where allowed within the legal constraints, access to safe abortion should be facilitated without prejudice and stigmatization. The healthcare providers should offer proper pre-abortion counselling and assessment, and choice of the abortion method should be made based on the gestational age and local expertise. Both medical and surgical methods are available for the effective termination of first- and second-trimester pregnancies. Most recommended regimens for medical abortion involve the use of misoprostol with or without mifepristone, whereas surgical abortions generally employ suction evacuation of the uterus. Providers of abortion service should be familiarized with the evidence-based guidelines and protocols published by various authorities on the abortion procedures and postabortion care, as well as means to prevent complications.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!